Â鶹´«Ã½É«ÇéƬ

Journal News

Seeking the sweet spot to beat a pig parasite

Senegal Carty
By Senegal Carty
July 16, 2024

Outbreaks of the nematode , also known as porcine whipworm, can be costly for pig farmers and inflict suffering on animals with severe infections. This worm reproduces in pigs’ digestive tracts, causing dehydration, malnourishment and sometimes death. Understanding how a pig's immune system reacts to T. suis is an important step toward developing better strategies for helping animals to clear it.

Iain B.H. Wilson’s lab at the Universität für Bodenkultur in Vienna, in collaboration with Richard Cummings’ lab at Harvard Medical School, tackled the question of how the pig immune system recognizes sugar molecules, or glycans, found on T. suis proteins. The group recently reported in the journal Â鶹´«Ã½É«ÇéƬ & Cellular Proteomics. Lead author Barbara Eckmair, along with co-author Katharina Paschinger and Wilson walked us through their process, their findings and the importance of this study.

Organically farmed pigs are at especially high risk of whipworm infection. New research into their immune responses to sugars made by this parasite could help scientists develop vaccines against it.
Organically farmed pigs are at especially high risk of whipworm infection. New research into their immune responses to sugars made by this parasite could help scientists develop vaccines against it.

The group extracted glycans from worms and then separated different types of glycans using high-performance liquid chromatography, a technique that isolates compounds within a mixture based on how easily they separate due to their size and structure. They then created arrays of spots made up of the separated glycans. Using these arrays, they tested several innate immune system proteins, as well as immunoglobulin G and M, or IgG and IgM, antibodiesfrom T. suis–infected pigs, to see how well they bound to each glycan spot.

“Some large molecular-weight glycans seemed to have the bulk of the response to the antisera,” Wilson said. “So that left the question as to what the exact structures were.”

They found that many fucose residues were common, as well as a zwitterion called phosphorylcholine, and up to eight phosphorylcholine residues could decorate some of the glycans.

“Lots of other nematodes have phosphorylcholine on their N-glycans,” he said, “and these are very often associated with immune system downregulation.”

However, this was the first time such large structures had been found in T. suis.

Wilson said this research is especially impactful for organic farming because animals raised this way receive fewer antiparasitic drugs and are at higher risk of worm infections. suggest that vaccination against these parasites is an attractive potential strategy.

“There are indications from Haemonchus, which is a sheep parasite, that the glycans would be important for making the vaccine," Wilson said.

When asked about the next steps for this research,  co-author Paschinger said that determining which glycans are bound by IgE, an antibody that plays a key role in the immune response to parasites, is an important question to answer.

Eckmair, the paper’s lead author, explained that IgE binding could not be addressed in this study because the reagents needed to test pig IgE binding are difficult to procure, but she said future experiments could tackle this and many other questions.

“Of course, there is more immunological work that we could do, because we still have some of the arrays left,” Eckmair said. “This was really a lucky case because we have so much material that we could test.”

This research is not only a step toward understanding the pig immune response to T. suis; by helping researchers understand the immune response to glycans found in the human whipworm, it might lead to medical advances for humans as well.

Enjoy reading ASBMB Today?

Become a member to receive the print edition four times a year and the digital edition weekly.

Learn more
Senegal Carty
Senegal Carty

Senegal Carty recently graduated from Boston University Chobanian and Avedisian School of Medicine with a Ph.D. in molecular and translational medicine. She is an ASBMB Today volunteer contributor.

Related articles

From the journals: MCP
Connor O'Hara
From the journals: MCP
Nivedita Uday Hegdekar
Saving the bees with proteomics
Elizabeth Stivison
From the journals: MCP
Courtney Chandler

Get the latest from ASBMB Today

Enter your email address, and we’ll send you a weekly email with recent articles, interviews and more.

Latest in Science

Science highlights or most popular articles

Elucidating how chemotherapy induces neurotoxicity
Award

Elucidating how chemotherapy induces neurotoxicity

Dec. 2, 2024

Andre Nussenzweig will receive the Bert and Natalie Vallee Award at the 2025 ASBMB Annual Meeting, April 12–15 in Chicago.

Where do we search for the fundamental stuff of life?
Essay

Where do we search for the fundamental stuff of life?

Dec. 1, 2024

Recent books by Thomas Cech and Sara Imari Walker offer two perspectives on where to look for the basic properties that define living things.

UCLA researchers engineer experimental drug for preventing heart failure after heart attacks
News

UCLA researchers engineer experimental drug for preventing heart failure after heart attacks

Nov. 30, 2024

This new single-dose therapy blocks a protein that increases inflammation and shows promise in enhancing muscle repair in preclinical models.

The decision to eat may come down to these three neurons
News

The decision to eat may come down to these three neurons

Nov. 28, 2024

The circuit that connects a hunger-signaling hormone to the jaw to stimulate chewing movements is surprisingly simple, Rockefeller University researchers have found.

Curiosity turned a dietitian into a lipid scientist
Award

Curiosity turned a dietitian into a lipid scientist

Nov. 27, 2024

Judy Storch will receive the Avanti Award in Lipids at the 2025 ASBMB Annual Meeting, April 12–15 in Chicago.

From receptor research to cancer drug development: The impact of RTKs
Award

From receptor research to cancer drug development: The impact of RTKs

Nov. 26, 2024

Joseph Schlessinger will receive the ASBMB Herbert Tabor Research Award at the 2025 ASBMB Annual meeting, April 12–15 in Chicago.